Search

Your search keyword '"Spring, Denise J."' showing total 185 results

Search Constraints

Start Over You searched for: Author "Spring, Denise J." Remove constraint Author: "Spring, Denise J."
185 results on '"Spring, Denise J."'

Search Results

2. Histone demethylase KDM5D upregulation drives sex differences in colon cancer

3. Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer

5. Telomere dysfunction instigates inflammation in inflammatory bowel disease

6. Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth

8. Data from Oncogenic KRAS Drives Lipofibrogenesis to Promote Angiogenesis and Colon Cancer Progression

9. Supplementary Figure S7 from Oncogenic KRAS Drives Lipofibrogenesis to Promote Angiogenesis and Colon Cancer Progression

10. Supplementary Table S5 from Oncogenic KRAS Drives Lipofibrogenesis to Promote Angiogenesis and Colon Cancer Progression

11. PAF promotes stemness and radioresistance of glioma stem cells

13. Oncogenic KRAS drives lipo-fibrogenesis to promote angiogenesis and colon cancer progression

14. Telomere dysfunction activates YAP1 to drive tissue inflammation

16. Supplementary Table from Synthetic Essentiality of Tryptophan 2,3-Dioxygenase 2 in APC-Mutated Colorectal Cancer

21. Supplementary Figures S1-9 from Tumor Microenvironment Remodeling Enables Bypass of Oncogenic KRAS Dependency in Pancreatic Cancer

22. Data from Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment

23. Supplementary Table S1 from Tumor Microenvironment Remodeling Enables Bypass of Oncogenic KRAS Dependency in Pancreatic Cancer

24. Data from Tumor Microenvironment Remodeling Enables Bypass of Oncogenic KRAS Dependency in Pancreatic Cancer

25. Supplementary Data from Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment

27. Effective combinatorial immunotherapy for castration-resistant prostate cancer

28. Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer

29. Abstract PR011: Histone demethylase KDM5D drives sex-specific differences in colorectal cancer

30. Abstract IA014: Synthetic essentiality identifies TDO2 as a key target in APC-deficient CRC

31. Synthetic Essentiality of Tryptophan 2,3-Dioxygenase 2 in APC-Mutated Colorectal Cancer

33. Histone demethylase KDM5D drives sex-specific differences in colorectal cancer

34. Chromatin Regulator CHD1 Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Deficient Prostate Cancer

35. Tumor Microenvironment Remodeling Enables Bypass of Oncogenic KRAS Dependency in Pancreatic Cancer

36. Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment

41. AR-negative prostate cancer is vulnerable to loss of JMJD1C demethylase.

42. USP21 deubiquitinase promotes pancreas cancer cell stemness via Wnt pathway activation

44. KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer

47. Erratum: Effective combinatorial immunotherapy for castration-resistant prostate cancer

48. PAF promotes stemness and radioresistance of glioma stem cells.

49. Inhibition of Toll-like Receptor 4 With Eritoran Attenuates Myocardial Ischemia-Reperfusion Injury

Catalog

Books, media, physical & digital resources